Media Coverage (Healthspan)
Healthspan
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Healthspan
- Healthy Aging
- Infectious Disease
- Microbiome
- Pregnancy Health
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
AI and the future of human health: Leroy Hood on the new age of ‘scientific wellness’
Lee Hood was a guest on the Geekwire Podcast and discussed “The Age of Scientific Wellness,” the new book by Lee and Nathan Price.
Is predictive, personalized treatment the future of medicine?
Nathan Price talked about his book “The Age of Scientific Wellness” in an interview with author Matthew LaPlante for Utah Public Radio’s “Undisciplined” program.
The AI will see you now
The Wall Street Journal published an essay adapted from “The Age of Scientific Wellness,” a book authored by Drs. Lee Hood and Nathan Price.
The future of medicine is personalized, predictive and in your hands
On this podcast episode, Lee Hood and Nathan Price discuss their book, “The Age of Scientific Wellness,” the role of AI in improvising human lifespan, immunotherapy, NMN, gene editing, Alzheimer’s disease, and several other topics.
Blood-Based Omics Signatures Reflect 'Biological' BMI, Metabolic Health
Using multiomic, blood-based biomarkers, ISB researchers developed signatures of obesity and metabolic disease that can find affected individuals more accurately than body mass index based on height and weight.
Science for the 21st century: Understanding systems biology
Senior Research Scientist Jared Roach discussed complex interactions within biological systems, how we can update the study of biology for the 21st century, how computational and mathematical analysis can help us understand biological systems, and more.
The new science of wellness
In this special report, Scientific American explores how the emerging field of phenomics is merging modern science and technology with ancient and modern ways to keep people healthy to harness health-related data to stop disease before it starts.
Second Opinion: The path toward an Alzheimer's cure may not be a drug
In this guest column for The Los Angeles Times, ISB Co-founder and Professor Dr. Lee Hood shares his personal and professional experience with Alzheimer’s disease.